STAAR Surgical stock rises after CTO appointment
Published on 09/03/2026 at 14:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
STAAR Surgical Company (US8577001096) stock closed at USD 23.13 on CBOE on September 2, 2026, down 1.74 percent on the day and up 1.23 percent over five days. The latest catalyst came on September 2, 2026, when Marketscreener reported that STAAR Surgical named Ben Park as chief technology officer.
Q2 revenue stayed above estimates
For the second quarter ended July 3, 2026, the company reported revenue of USD 93.5 million and EPS of USD 0.16, according to the Marketscreener item that summarized the earnings release. The same report said FactSet had expected USD 90.6 million in revenue and EPS of USD 0.14, so the quarter came in above that comparison on both lines.
That earnings snapshot also placed the move in context for investors: revenue beat the estimate by USD 2.9 million, while EPS was USD 0.02 above the FactSet figure. A new technology chief and a quarter that cleared consensus by that margin keep attention on execution, not just on the share price.
Market action stays mixed
The stock started September with a modest year-to-date gain of 0.22 percent on Marketscreener, even after the 1.74 percent drop in the latest CBOE close. Over the same five-day window, the share still showed a 1.23 percent rise, which underlines how narrow the recent trading range has been.
Latest STAAR Surgical filing and shares
The latest quarterly numbers and the new technology appointment give the shares a clear operating and management angle.
ICL remains the core product
STAAR Surgical remains tied to its implantable collamer lens business, which is the product line investors track when they look at revenue momentum and regional demand. The Q2 2026 report and the leadership change both matter because they touch the same operating engine behind the stock.
Price and trading view
STAAR Surgical stock traded at USD 23.13 on September 2, 2026, on CBOE. That level leaves the shares close to flat for 2026, with the year-to-date move at 0.22 percent.
STAAR Surgical key data
- Company: STAAR Surgical Company
- ISIN: US8577001096
- Ticker: STAA
- Trading venue: CBOE
- Price (as of September 2, 2026, 21:59:54): USD 23.13
- Market capitalization: not provided in the available sources
- Sector / Industry: Medical Supplies / Medical Devices
- Index membership: not provided in the available sources
